Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and tolerability of drospirenone 4 mg oral contraception in female adolescents
2013-005234-37Phase 3Completed
- Sponsor
- Laboratorios Leon Farma
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of drospirenone, sponsored by Laboratorios Leon Farma. Primary endpoints: Treatment-emergent adverse events and Bleeding pattern. Started Jan 2014; status: completed.
02
Drugs
drospirenone
Beyond the preview
Go deeper on 2013-005234-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005234-37.